Effective treatment of glioblastoma multiforme with oncolytic virotherapy: a case-series
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Oncology ; 10 (2020). - Art.-Nr. 702. - eISSN 2234-943X
- Keyword
-
Glioblastom
Immuntherapie
Newcastle-Krankheit
- Event
-
Veröffentlichung
- (where)
-
Ulm
- (who)
-
Universität Ulm
- (when)
-
2020
- Creator
-
Gesundheit, Benjamin
Ben-David, Eliel
Posen, Yehudit
Ellis, Ronald
Wollmann, Guido
Schneider, E. Marion
Aigner, Karl
Brauns, Lars
Nesselhut, Thomas
Ackva, Ingrid
Weisslein, Christine
Thaller, Arno
- DOI
-
10.18725/OPARU-42452
- URN
-
urn:nbn:de:bsz:289-oparu-42528-7
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gesundheit, Benjamin
- Ben-David, Eliel
- Posen, Yehudit
- Ellis, Ronald
- Wollmann, Guido
- Schneider, E. Marion
- Aigner, Karl
- Brauns, Lars
- Nesselhut, Thomas
- Ackva, Ingrid
- Weisslein, Christine
- Thaller, Arno
- Universität Ulm
Time of origin
- 2020
Other Objects (12)
Oncolytic virotherapy of glioblastoma
Developing a new strategy to enhance oncolytic virotherapy in glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Developing a new strategy to enhance oncolytic virotherapy in glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy
Effects of virus-induced immunogenic cues on oncolytic virotherapy
Oncolytic virotherapy of glioblastoma
Developing a new strategy to enhance oncolytic virotherapy in glioblastoma
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Oncolytic Virotherapy of Canine and Feline Cancer
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Immunological aspects of YB-1-dependent oncolytic virotherapy
Immunological aspects of YB-1-dependent oncolytic virotherapy
Overcoming the limitations of locally administered oncolytic virotherapy
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
Key parameters of measles virus production for oncolytic virotherapy